Retatrutide (5 mg, 10 mg)

Multi-Receptor Agonist Peptide for Advanced Metabolic Research

Retatrutide is an innovative investigational peptide designed as a triple agonist for GLP-1, GIP, and glucagon receptors. This unique multi-pathway action makes it one of the most promising compounds in metabolic and obesity research. By engaging multiple hormone receptors, Retatrutide has been studied for its potential to regulate appetite, enhance energy expenditure, and support weight-management models. Researchers value it for its broad applications in metabolic disease studies and endocrine research. Atomix Research provides Retatrutide in high-purity form, ideal for precise laboratory analysis